BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Cadrenal Therapeutics Inc. (NASDAQ:CVKD)

3 posts

Biotech NewsCadrenal Therapeutics (CVKD) Surges in Attention After Q3 2025 Update Reveals Big Pipeline Moves

  • BioTech Health X
  • December 7, 2025
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) is an emerging biopharmaceutical company focused on developing next-generation anticoagulant therapies designed to…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCadrenal (CVKD) Targeted at $30 After Acquiring Phase 2-Ready Frunexian

  • BioTech Health X
  • October 1, 2025
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a clinical-stage biopharmaceutical company focused on addressing critical unmet needs in cardiovascular medicine,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWall Street Is Watching Cadrenal Therapeutics (CVKD)’s Next Move

  • BioTech Health X
  • August 14, 2025
Cadrenal Therapeutics Inc. (NASDAQ:CVKD) is a biopharmaceutical company dedicated to developing transformative therapeutics that address the significant limitations…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 5 Best Micro Cap Healthcare Stocks to Watch Today
  • CorMedix (CRMD) Posts 157% Revenue Growth and $26M in Profit but There’s an Acquisition Twist
  • Mirum Pharmaceuticals (MIRM) Flexes 46% LIVMARLI Sales Growth
  • ADMA Biologics (ADMA) Delivers 26% ASCENIV Growth but Its Other Numbers Tell a Different Story
  • Rigel Pharmaceuticals (RIGL) Turns 14% Product Sales Growth Into a $17.3M Profit
Featured Posts
    • October 18, 2026
    5 Best Micro Cap Healthcare Stocks to Watch Today
    • October 17, 2026
    CorMedix (CRMD) Posts 157% Revenue Growth and $26M in Profit but There’s an Acquisition Twist
    • October 17, 2026
    Mirum Pharmaceuticals (MIRM) Flexes 46% LIVMARLI Sales Growth
    • October 17, 2026
    ADMA Biologics (ADMA) Delivers 26% ASCENIV Growth but Its Other Numbers Tell a Different Story
    • October 17, 2026
    Rigel Pharmaceuticals (RIGL) Turns 14% Product Sales Growth Into a $17.3M Profit
Recent Posts
  • Progyny (PGNY) Generates $50.4M in Quarterly Cash Flow
    • October 17, 2026
  • Nuvation Bio (NUVB) Posts 25% Drug Sales Growth
    • October 17, 2026
  • Top 6 Small-Cap Healthcare Stocks to Buy Right Now
    • October 17, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,126)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top